BROUGHT
TO YOU BY
ASSOCIATE
SPONSORS
Friday, July 3, 2015 | Latest E-book
You are here: Home » Topics » » Bloomberg » Videos

Lupin, Cipla bid for UCB's U.S. generic drugs portfolio - Bloomberg| Reuters

Jun 02, 2015    

MUMBAI Generic drugmakers Lupin Ltd (LUPN.NS) and Cipla Ltd (CIPL.NS) are among the companies bidding for top Belgian drugmaker UCB SA's (UCB.BR) U.S. generic drugs business, Bloomberg reported on Monday, citing unnamed people with knowledge of the matter. Lupin and Cipla, which rank among India's top five drugmakers by sales, submitted first-round offers in late April for UCB's Kremers Urban Pharmaceuticals Inc unit that could be valued at about $1 billion, Bloomberg said.A UCB spokeswoman told Reuters that a sale process involving multiple parties was ongoing, and the company hopes to reach ...

Read More